Short-term, high-dose hydroxychloroquine corneal toxicity
Purpose: To describe the corneal findings and management of a 61-year-old female with vortex keratopathy following short term, high dose hydroxychloroquine used in the setting of a clinical trial for recurrent breast cancer. Observations: The patient was found to have significant corneal vortex kera...
Main Authors: | Daniel E. Savage, Ronald Plotnik, Rachel A.F. Wozniak |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | American Journal of Ophthalmology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993619301355 |
Similar Items
-
Macular toxicity after short-term hydroxychloroquine therapy
by: Isil Pasaoglu, et al.
Published: (2019-01-01) -
Hydroxychloroquine as Prophylaxis for COVID-19: A Review
by: Manuela Monti, et al.
Published: (2020-12-01) -
Unusual Fundus Autofluorescence Appearance in a Patient with Hydroxychloroquine Retinal Toxicity
by: Sleiman Abou-Ltaif
Published: (2015-06-01) -
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
by: Chunfeng Li, et al.
Published: (2020-08-01) -
Over-Treated Corneal Abscess May Be Toxic Keratopathy
by: P. Rubino, et al.
Published: (2010-06-01)